We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Russian government has belatedly stepped up funding to combat the growing problem of HIV/AIDS in Russia, which has one of the fastest-rising infection rates in the world.
SAFC Biosciences, a member of the Sigma-Aldrich Group (Nasdaq: SIAL), and Chromos Molecular Systems Inc. ("Chromos"; TSX:CHR), have entered into a non-exclusive co-marketing arrangement whereby SAFC Biosciences and Chromos will jointly market and offer Chromos' proprietary ACE System for cell line engineering for protein
production applications.
Guilford Pharmaceuticals Inc. (Nasdaq: GLFD) today announced that its stockholders approved the merger transaction pursuant to which Guilford will become a wholly-owned subsidiary of MGI PHARMA, INC. (Nasdaq: MOGN), an oncology and acute care focused biopharmaceutical company located in Bloomington, Minnesota.
German drugs and chemicals group Altana (ALTG.DE: Quote, Profile, Research) (AAA.N: Quote, Profile, Research) has agreed to acquire Kelstar International, a U.S. producer of coatings for the paper and packaging industry, it said on Thursday.
Isotechnika Inc. ("Isotechnika") and Atrium Medical Corporation ("Atrium") jointly announced today the signing of an exclusive worldwide licensing agreement for the use of TAFA93 and ISA247 specifically with drug eluting devices for the non-systemic treatment of vascular, cardiovascular disorders, target vessel and tissue disorders.
Sun Pharma announced that it has signed an agreement to buy a manufacturing facility in Bryan, Ohio from Valeant Pharmaceuticals International. Terms of the transaction were not disclosed.
As part of its expansion strategy in the CEE region, Iceland-based Actavis Group, the international generic pharmaceutical company, has announced on Friday that it has acquired the generic business of the Hungarian pharmaceutical company, Kéri Pharma.
A recent survey suggests that years of South African pensioners'
exclusion from company healthcare schemes is having a knock-on effect on state finances, as the elderly are forced to rely on public provision.